Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.19 USD | +1.92% | -2.64% | +1.16% |
May. 13 | Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.16% | 914M | |
+31.37% | 588B | |
-2.69% | 364B | |
+20.38% | 326B | |
+5.61% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.39% | 167B | |
+0.57% | 161B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Wedbush Lifts Liquidia Technologies' Price Target to $6 From $2; Neutral Rating Kept